Alexander Krichevsky
Directeur/Bestuurslid bij Omnimmune Corp.
Profiel
Alexander Krichevsky currently works at Omnimmune Corp., as Director from 2001.
Mr. Krichevsky also formerly worked at The Trustees of Columbia University in The City of New York, as Director-Tissue Culture & Hybridoma Laboratories, Omnimmune Holdings, Inc., as Director, Vice President & Research Director in 2010, Allegheny-Singer Research Institute, as Director-Monoclonal Antibody Development, and Invitro Technologies, as Senior Vice President-Research & Development.
Actieve functies van Alexander Krichevsky
| Bedrijven | Functie | Begin |
|---|---|---|
Omnimmune Corp.
 Omnimmune Corp. Medical/Nursing ServicesHealth Services Omnimmune Corp. develops cancer treatment including prophylactic and therapeutic vaccines, monoclonal antibodies, and gene-based products. The company was founded in 1994 and is headquartered in Halifax, NS. | Directeur/Bestuurslid | 29-12-2009 |
Eerdere bekende functies van Alexander Krichevsky
| Bedrijven | Functie | Einde |
|---|---|---|
| OMNIMMUNE HOLDINGS, INC. | Hoofd Techniek/Wetenschap/O&O | 11-08-2010 |
| Invitro Technologies | Hoofd Techniek/Wetenschap/O&O | - |
| Allegheny-Singer Research Institute | Corporate Officer/Principal | - |
| The Trustees of Columbia University in The City of New York | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| OMNIMMUNE HOLDINGS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Omnimmune Corp.
Omnimmune Corp. Medical/Nursing ServicesHealth Services Omnimmune Corp. develops cancer treatment including prophylactic and therapeutic vaccines, monoclonal antibodies, and gene-based products. The company was founded in 1994 and is headquartered in Halifax, NS. | Health Services |
| Allegheny-Singer Research Institute | |
| Invitro Technologies |
